We then focused on exploring the functions of INHBA in the progression of breast cancer and demonstrated that inhibition of its expression could markedly attenuate the proliferation and epithelial–mesenchymal transition (EMT) of breast cancer cells. Here, INHBA is linked to breast carcinoma.